Clinical Trials — Genitourinary / Prostate Cancer

                                                                                             Click on trial for description and contact information.

A Phase I Open-Label, Sequential Dose Escalation Study Investigating the Safety, Tolerability, and Pharmacokinetics of Intravenous Lipotecan® (TLC388 HCl for Injection) when administered to Patients with Advanced Solid Tumors

For more information or to refer a patient, contact:

Pam Bourbo, RN, MPH, OCN, CCRC

manager

Cancer Clinical Research Unit

(706) 721-2730

pbourbo@mcg.edu

 

Revised September 12, 2009.  Please send comments, suggestions or questions about this page to Cancer Team, cancer@mcg.edu.